$ 11 400 to publish a paper in Nature Neuroscience?? R 174 456 in today’s exchange rate! Really? Ridiculous. Who can afford that? In South Africa it’s the price of a brand new car, not even a 2nd hand. See below. This is the type of thing that drives global scientific inequity
🗨️“In countries with a higher incidence of TB, you can’t consider COVID-19 to be an isolated disease.”
On #WorldTBDay, group leader Robert Wilkinson explains his team's work with @UCT_News to understand interactions between #COVID19 and #tuberculosis. https://t.co/oW2MTwm71q
We are involved with in bovine TB susceptibility studies in African buffalo. Here we collaborated with Deon de Jager, Cindy Harper and Paulette Bloom to investigate diversity, inbreeding and demographic history in African buffalo genomes https://t.co/wDZiaNXJJC
"UK variant" (B.1.1.7) and "SA variant" (B.1.351) discovered in Ghana - but in travelers from the rest of Africa, not these 2 countries. Shows how important genomic surveillance is and how wrong naming variants after places is. Congrats @WACCBIP_UG
Excited to announce a publication from CAN Fellow @BrigitteGlanzm1 in @SciReports reporting on sequencing the first 6 human whole genomes on the African continent, at the @MRCza Genomics Centre with @StellenboschUni https://t.co/tIE0N9Ebrd
Today we moved into the brand new Biomedical Research Institute @SUhealthsci -absolutely gorgeous & inviting space! Our 1st floor colour scheme is my favourite! Wish everyone lots of happiness and success while doing #science in our new home @SuMBHG@SUTBHostGen@SUpsychgenetics
📰 New research in @ScienceMagazine from George Kassiotis’s group at the Crick and @ucl has found that some children have antibodies created during infection with common cold coronaviruses that can also target SARS-CoV-2.
#COVID19 | @KevinWNg https://t.co/dFcW2WguCM
No. Not loadshedding again. How much more can the people take? You steal the country blind. You mismanage electricity supply. But you fixate on cigarettes and alcohol? Basta!
A pandemic of the magnitude of #COVID19 did not convince EU politicians of the importance of investing in research? The same ones that wanted to have new therapies and vaccines ready in a couple of months?
https://t.co/Wgaxl8ViYg
A Crick team has found that the protein interferon lambda can inhibit lung tissue repair after a virus if it’s used as a treatment for an extended period. It shows that using it to treat viruses, including SARS-CoV-2, needs to be carefully thought through. https://t.co/epdyq9WOjR
It would be an utterly stupid, dangerous & unenforceable decision to continue with the ban. The virus is going to be with us for at least another year. The black market will become a massive criminal enterprise & smoking & drinking will go on, so no health benefits
I'm delighted to share the pre-print of the "manifesto" of our #COVID19 Human Genetic Effort, which was posted online by Cell https://t.co/8Y2ReDKhO2 Thoughts, hands, suggestions, critiques, samples, reagents, and even funds welcome 😀 #Covid_19#coronavirus@CellPressNews
Type I IFN immunoprofiling in COVID-19 patients https://t.co/Y2jdwxLZYv
Our findings highlight defect of IFN-I in COVID-19 patients and suggest recombinant IFN could be beneficial in patients especially within the first week of SARS-CoV2 infection.